Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-14-002794
Filing Date
2014-06-09
Accepted
2014-06-09 16:10:49
Documents
11
Period of Report
2014-04-30

Document Format Files

Seq Description Document Type Size
1 c77734_10q.htm 10-Q 742531
2 c77734_ex31-1.htm EX-31.1 9212
3 c77734_ex31-2.htm EX-31.2 9210
4 c77734_ex32-1.htm EX-32.1 3350
5 c77734_ex32-2.htm EX-32.2 3345
  Complete submission text file 0000930413-14-002794.txt   7074239

Data Files

Seq Description Document Type Size
6 enz-20140430.xml EX-101.INS 1313970
7 enz-20140430.xsd EX-101.SCH 53092
8 enz-20140430_cal.xml EX-101.CAL 35712
9 enz-20140430_def.xml EX-101.DEF 231522
10 enz-20140430_lab.xml EX-101.LAB 392497
11 enz-20140430_pre.xml EX-101.PRE 240433
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 14899329
SIC: 8071 Services-Medical Laboratories